27-12-2022 23:54 via drugs.com

Per-Patient Costs of Metastatic Prostate Cancer Estimated at $31,427

TUESDAY, Dec. 27, 2022 -- The estimated annual per-patient costs attributable to metastatic prostate cancer are $31,427, according to a study published in the January issue of Urology Practice.
T. Anders Olsen, from the Emory University School of...
Read more »